Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

A serosurvey evaluation of the school-based measles 'catch-up' immunisation campaign in Victorian school-aged children.

Riddell MA, Leydon JA, Ugoni A, Kelly HA.

Aust N Z J Public Health. 2001 Dec;25(6):529-33.

PMID:
11824989
2.
3.
4.

[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].

Zäch K, Nicoara C, Germann D, Matter L.

Schweiz Med Wochenschr. 1998 Apr 25;128(17):649-57. German.

PMID:
9622837
5.

Serological assessment of measles-rubella vaccination catch-up campaign among university students.

Takeuchi J, Goto M, Kawamura T, Hiraide A.

Pediatr Int. 2014 Jun;56(3):395-9. doi: 10.1111/ped.12285.

PMID:
24417932
6.

Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine.

Roberts RJ, Sandifer QD, Evans MR, Nolan-Farrell MZ, Davis PM.

BMJ. 1995 Jun 24;310(6995):1629-32.

7.

[Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students].

Yoshida N, Tsumura N, Toyomasu K, Sagawa K.

Sangyo Eiseigaku Zasshi. 2007 Jan;49(1):21-6. Japanese.

8.

[Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].

Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.

Praxis (Bern 1994). 1999 Jun 10;88(24):1069-77. German.

PMID:
10420798
9.

[Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].

Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M.

An Esp Pediatr. 1987 Jul;27(1):27-31. Spanish.

PMID:
3662251
10.
11.

Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme.

Tharmaphornpilas P, Yoocharean P, Rasdjarmrearnsook AO, Theamboonlers A, Poovorawan Y.

J Health Popul Nutr. 2009 Feb;27(1):80-6.

12.

Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010.

Ang LW, Lai FY, Tey SH, Cutter J, James L, Goh KT.

Epidemiol Infect. 2013 Aug;141(8):1721-30. doi: 10.1017/S0950268812002130.

PMID:
22999024
13.

Measles, mumps and rubella immunisation in children at risk of infection with human immunodeficiency virus.

Molyneaux PJ, Mok JY, Burns SM, Yap PL.

J Infect. 1993 Nov;27(3):251-3.

PMID:
8308316
14.

Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.

Kim SS, Han HW, Go U, Chung HW.

Vaccine. 2004 Dec 2;23(3):290-7.

PMID:
15530670
15.
16.

Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.

Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.

Pediatr Infect Dis J. 1996 Aug;15(8):687-92.

PMID:
8858673
17.
18.

Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.

Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE.

J Infect Dis. 2004 May 1;189 Suppl 1:S116-22.

PMID:
15106100
19.

Prevalence of measles, mumps, rubella, and varicella susceptibility among health science students in a University in India.

Arunkumar G, Vandana KE, Sathiakumar N.

Am J Ind Med. 2013 Jan;56(1):58-64. doi: 10.1002/ajim.22046.

20.

Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.

Eick AA, Hu Z, Wang Z, Nevin RL.

Vaccine. 2008 Jan 24;26(4):494-501.

PMID:
18155326

Supplemental Content

Support Center